• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Exclusives

Recent news which mentions Exclusives

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
EXCLUSIVE: Inuvo Clocks 57% Topline Growth, Margin Shrinks Due To Product Mix
Today 8:02 EDT
Tickers INUV NEWS
Tags INUV News Earnings
From Benzinga
EXCLUSIVE: Adial Pharmaceuticals Secures FDA End of Phase 2 Meeting Request To Discuss Upcoming Clinical Development Plan For Lead Program
May 08, 2025
Tickers ADIL NEWS
Tags Benzinga Market/Moving Exclusives FDA
From Benzinga
EXCLUSIVE: Mira Pharmaceuticals Board Approves SKNY Pharma Acquisition, Establishing Combined Enterprise Value Over $60 Million
May 08, 2025
Tickers MIRA NEWS
Tags Top Stories News Market News
From Benzinga
EXCLUSIVE: Aduro's Deal With Cleanfarms Targets Farm Plastic Recycling Revolution And Scalable Sustainability
May 08, 2025
Tickers ADUR NEWS
Tags Stories That Matter Market News Market/Moving Exclusives
From Benzinga
They Turned Fruit Bouquets Into A $500 Million-A-Year Business—Now They're Selling THC. Here's Why
May 07, 2025
Tags Thomas Winstanley Cannabis Benzinga
From Benzinga
EXCLUSIVE: Trump's Approval Rating Drops In Reader Survey After 100 Days, Could Stock Market Be To Blame?
May 07, 2025
Tickers SPY
Tags Emerson College election poll Benzinga Poll
From Benzinga
EXCLUSIVE: Alzamend Neuro Partners with QMENTA To Advance AI-Powered Imaging For Is Phase 2 Trial Of Lead Program
May 07, 2025
Tickers ALZN NEWS
Tags Biotech Health Care Exclusives
From Benzinga
EXCLUSIVE: Nobody Believed A 100% International ETF Could Beat 1,000+ Rivals, Until This CEO Proved Them Wrong — His Mantra? 'Precision Over Breadth'
May 06, 2025
Tickers BCIL BCUS
Tags Interview International Equity ETFs Market News
From Benzinga
Exclusive: Expert Explains How This Gold ETF Lets You Physically Hold Your Wealth And Why Investors Are Quietly Rushing In
May 06, 2025
Tickers GLD IAU OUNZ
Tags ETFs GLD Specialty ETFs
From Benzinga
EXCLUSIVE: DeFi Development Corp Expands Digital Asset Portfolio, Holds $58.5 Million In Solana Tokens
May 06, 2025
Tickers DFDV NEWS
Tags DFDV Top Stories Cryptocurrency
From Benzinga
EXCLUSIVE: MIRA Pharmaceuticals Lead Program Ketamir-2 Shows No Brain Toxicity In FDA-Mandated Study
May 06, 2025
Tickers MIRA NEWS
Tags Market News General Briefs
From Benzinga
Exclusive: HF Foods Launches E-Commerce Platform For Restaurant Staff Nationwide
May 06, 2025
Tickers HFFG NEWS
Tags Briefs General HFFG
From Benzinga
EXCLUSIVE: Thrill Ride With A Dividend? New ETF Marries MicroStrategy Leverage With Income
May 05, 2025
Tickers MST MSTR
Tags Stories That Matter Exclusives Benzinga
From Benzinga
EXCLUSIVE: Netflix Customers Excited For Original Movies, 'Squid Game,' 'Stranger Things,' NFL: 60% Say This Tops 2025 Must-Watch List
May 05, 2025
Tickers NFL NFLX WWE
Tags Trading Ideas Exclusives Benzinga
From Benzinga
EXCLUSIVE: Lantern Advances Breast Cancer Drug Candidate With FDA Clearance For Early-Stage Trial
May 05, 2025
Tickers LTRN NEWS
Tags Stories That Matter Benzinga Market/Moving Exclusives
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap